Results 221 to 230 of about 5,148,522 (246)
Some of the next articles are maybe not open access.
Value Foundations for Drug Use
Journal of Drug Issues, 1977This article investigates the relationship of value foundations to the use of drugs. The argument is presented that it is logically impossible to make drug use decisions without evaluating the outcomes of various alternatives and choosing the most highly valued in the circumstances.
openaire +2 more sources
Values in evaluation – The use of rubrics
Evaluation and Program Planning, 2017Rubrics are used by evaluators who seek to move evaluations from being mere descriptions of an evaluand (i.e., the programme, project or policy to be evaluated) to determining the quality and success of the evaluand. However, a problem for evaluators interested in using rubrics is the literature relating to rubric development is scattered and mostly ...
Pauline, Dickinson, Jeffery, Adams
openaire +2 more sources
Valuing vaccines using value of statistical life measures
Vaccine, 2014Vaccines are effective tools to improve human health, but resources to pursue all vaccine-related investments are lacking. Benefit-cost and cost-effectiveness analysis are the two major methodological approaches used to assess the impact, efficiency, and distributional consequences of disease interventions, including those related to vaccinations ...
Ramanan, Laxminarayan +3 more
openaire +2 more sources
Storageless value prediction using prior register values
Proceedings of the 26th International Symposium on Computer Architecture (Cat. No.99CB36367), 1999This paper presents a technique called register value prediction (RVP) which uses a type of locality called register-value reuse. By predicting that an instruction will produce the value that is already stored in the destination register, we eliminate the need for large value buffers to enable value prediction.
Dean M. Tullsen, John S. Seng
openaire +1 more source
Using Pharmacoeconomics to Value Pharmacotherapy
Clinical Pharmacology & Therapeutics, 2008Pharmacotherapeutic decisions are increasingly constrained in all clinical settings by the costs of drug treatment and medical care. Some biotech therapies (e.g., Avastin, Cerzyme, Herceptin, Gleevec, Erbitux) can cost from $10,000 to more than $100,000 per treatment episode.
openaire +2 more sources
• Hospitals to be valued on existing use
Nursing Standard, 1989All NHS hospitals are to be valued in preparation for the White Paper reforms, the DoH announced last week.
openaire +2 more sources
Use and value of metabolism databases
Drug Discovery Today, 1999A key objective during drug discovery is to ensure selection of lead compounds for development that have the optimum pharmacodynamic profile without undesirable toxicity. Metabolism plays a key role in determining the biological activity of compounds in vivo, and is therefore an important factor to consider during the discovery phase.
openaire +2 more sources